Bioxyne Limited Reports Revenue Surge and Widening Losses

Bioxyne Limited (AU:BXN) has released an update.

Bioxyne Limited, a company listed on the Australian Stock Exchange, has reported a significant 80% increase in revenue for the year ending 30 June 2024 compared to the previous year. However, this growth was accompanied by a substantial increase in losses, with the loss from ordinary activities after tax rising by 686%. The company also reported the liquidation of its subsidiaries in Switzerland and Japan, with businesses being absorbed by other entities within the group.

For further insights into AU:BXN stock, check out TipRanks’ Stock Analysis page.